120 related articles for article (PubMed ID: 15894095)
1. Prediction of cancer outcome with microarrays.
Goldhirsch A; Gelber RD; Viale G; Colleoni M; Coates AS
Lancet; 2005 May 14-20; 365(9472):1685-6; author reply 1686. PubMed ID: 15894095
[No Abstract] [Full Text] [Related]
2. Prediction of cancer outcome with microarrays.
Lee AH
Lancet; 2005 May 14-20; 365(9472):1685; author reply 1686. PubMed ID: 15894094
[No Abstract] [Full Text] [Related]
3. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
4. Predicting the future of breast cancer.
Borg A; Fernö M; Peterson C
Nat Med; 2003 Jan; 9(1):16-8. PubMed ID: 12514712
[No Abstract] [Full Text] [Related]
5. The molecular outlook.
Caldas C; Aparicio SA
Nature; 2002 Jan; 415(6871):484-5. PubMed ID: 11831227
[No Abstract] [Full Text] [Related]
6. Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes.
Saghatchian M; Mook S; Pruneri G; Viale G; Glas AM; Guerin S; Cardoso F; Piccart M; Tursz T; Delaloge S; van't Veer L
Breast; 2013 Oct; 22(5):682-90. PubMed ID: 23347730
[TBL] [Abstract][Full Text] [Related]
7. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
8. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
Bertucci F; Nasser V; Houlgatte R; Birnbaum D
Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
[TBL] [Abstract][Full Text] [Related]
9. High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy.
Naoi Y; Kishi K; Tanei T; Tsunashima R; Tominaga N; Baba Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S
Cancer; 2011 Feb; 117(3):472-9. PubMed ID: 20878674
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of gene expression profile data to guide adjuvant treatment in women with early-stage breast cancer.
Cosler LE; Lyman GH
Cancer Invest; 2009 Dec; 27(10):953-9. PubMed ID: 19909009
[No Abstract] [Full Text] [Related]
11. Clinical utility of the 70-gene MammaPrint profile in a Japanese population.
Ishitobi M; Goranova TE; Komoike Y; Motomura K; Koyama H; Glas AM; van Lienen E; Inaji H; Van't Veer LJ; Kato K
Jpn J Clin Oncol; 2010 Jun; 40(6):508-12. PubMed ID: 20110242
[TBL] [Abstract][Full Text] [Related]
12. Microarray technology and its effect on breast cancer (re)classification and prediction of outcome.
Cardoso F
Breast Cancer Res; 2003; 5(6):303-4. PubMed ID: 14580246
[No Abstract] [Full Text] [Related]
13. Gene-expression signatures in breast cancer.
Sotiriou C; Pusztai L
N Engl J Med; 2009 Feb; 360(8):790-800. PubMed ID: 19228622
[No Abstract] [Full Text] [Related]
14. [Therapeutic implications of advances in breast cancer biology].
Bertucci F; Gonçalves A; Maraninchi D
Rev Prat; 2004 Apr; 54(8):865-70. PubMed ID: 15274460
[TBL] [Abstract][Full Text] [Related]
15. Profiling familial breast cancer.
Lakhani SR; O'Hare MJ; Ashworth A
Nat Med; 2001 Apr; 7(4):408-10. PubMed ID: 11283660
[No Abstract] [Full Text] [Related]
16. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Lancashire LJ; Rees RC; Ball GR
Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
18. Can we replace the microscope with microarrays for diagnosis, prognosis and treatment of early breast cancer?
Glück S; Yip AY; Ng EL
Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S17-22. PubMed ID: 22316427
[TBL] [Abstract][Full Text] [Related]
19. The promise of microarrays in the management and treatment of breast cancer.
Chang JC; Hilsenbeck SG; Fuqua SA
Breast Cancer Res; 2005; 7(3):100-4. PubMed ID: 15987438
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
